meRfi®-GM
Probiotics (living agents) & Adiposity / Obesity
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Results from animal studies and human clinical trials suggest that various probiotics may potentially benefit body-related, biochemical, and metabolic parameters associated with obesity.
Bacteroides probiotics could be used for treating obesity
Preclinical Data
Clinical Data
The use of probiotics in obesity has increased, but without any logging. The databases of MEDLINE, Scopus, Web of Science, and Cochrane Library were searched for systematic reviews and meta-analyses in the last 15 years up to April 2020. From 549 identified intervention reports, we filtered 171 eligible studies, from which 24 full-text assays wer…
References (Sources)
- Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial
- Dose-dependent effects of multispecies probiotic supplementation on the lipopolysaccharide (LPS) level and cardiometabolic profile in obese postmenopausal women: a 12-week randomized clinical trial.
- Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial.
- Effects of probiotics on NAFLD in obese children and adolescents.
- Gut Microbiota and Obesity: A Role for ProbioticsReview
- Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial
- The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention